Abstract
For many patients around the world, medical drugs and treatments are either unavailable or unaffordable. Many of these patients are from poor economic backgrounds, and are not seen as a viable market by the pharmaceutical industry. Other patients (like those with rare diseases) do not represent a large enough consumer base to justify the pharmaceutical industry's significant research inve…